- Advanced search
|International Nonproprietary Names|
|Search PubMed clinical trials||plozalizumab|
|Search PubMed titles||plozalizumab|
|Search PubMed titles/abstracts||plozalizumab|
|Plozalizumab is a humanised anti-CCR2 monoclonal antibody, being investigated for its anti-inflammatory actions .
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
BLAST peptide analysis using the heavy and light chain variable amino acid sequences submitted with the INN record for plozalizumab, identifies 100% matches with sequences from patent US6696550 B2 .